A Multicenter, Postmarketing Observational (Noninterventional) Study to Evaluate the Safety of Fycompa for Injection in Patients With Partial-Onset Seizures (Including Secondarily Generalized Seizures) (Age 4 Years or Older) or Primary Generalized Tonic- Clonic Seizures (Age 12 Years or Older)
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
The purpose of this study is to determine the safety of Fycompa for injection after administration in participants with epilepsy (partial-onset seizures \[including secondarily generalized seizures\]) (age 4 years or older) or primary generalized tonic-clonic seizures (age 12 years or older).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 4
Healthy Volunteers: f
View:
• Participants with epilepsy who received the Fycompa for injection for the first time will be included.
Locations
Other Locations
Japan
1
RECRUITING
Tokyo
Contact Information
Primary
Eisai Inquiry Service
eisai-chiken_hotline@hhc.eisai.co.jp
0120-419-497
Time Frame
Start Date: 2024-11-18
Estimated Completion Date: 2028-06-15
Participants
Target number of participants: 110
Treatments
Fycompa
Related Therapeutic Areas
Sponsors
Leads: Eisai Co., Ltd.